Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel B7-H3-targeting ADC (R&D code: 7MW3711) has been approved by the NMPA to enter Phase Ib/II ...

During a live event, James W. Smithy, MD, MHS, and other oncologists discussed the tolerability of different immune ...

Survey shows executives turning to automation, AI, and domestic production amid geopolitical and regulatory shifts TAMPA, ...

Learn more about whether Jazz Pharmaceuticals plc or Merck & Co., Inc. is a better investment based on AAII's A+ Investor ...

Thus, in my opinion, Bristol-Myers Squibb is about a year ahead of Merck in the development of its subcutaneous version of the blockbuster PD-1 checkpoint inhibitor ... FDA's Orange Book, it ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

In the BRACELET-1 study, addition of pelareorep to paclitaxel chemotherapy yielded evidence of improved progression-free survival. Although it is worth noting that adding on the PD-L1 inhibitor ...

Learn more about whether Alvotech or TG Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which ...

While they help prevent autoimmunity, many cancers exploit this pathway to evade immune detection. PD-1 and PD-L1 inhibitors are immunotherapies designed to block this mechanism, allowing the immune ...

Stage 4 melanoma, otherwise known as metastatic melanoma, is the most advanced form of melanoma, a serious form of skin cancer that begins in cells known as melanocytes. Melanocytes produce the ...

This expansion will evaluate the combination of Decoy20 with BeiGene’s PD-1 checkpoint inhibitor, tislelizumab, with a focus on safety, dose optimization, and early signs of anti-tumor activity.

- Trials are designed to demonstrate whether the addition of Actimab-A to either KEYTRUDA ® or OPDIVO ® can result in improved patient outcomes - MDSCs – Myeloid Derived Suppressor Cells in ...